174 related articles for article (PubMed ID: 21629067)
1. Evaluation of prophylactic anticoagulation, deep venous thrombosis, and heparin-induced thrombocytopenia in 21 burn centers in Germany, Austria, and Switzerland.
Busche MN; Herold C; Krämer R; Knobloch K; Vogt PM; Rennekampff HO
Ann Plast Surg; 2011 Jul; 67(1):17-24. PubMed ID: 21629067
[TBL] [Abstract][Full Text] [Related]
2. Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.
Creekmore FM; Oderda GM; Pendleton RC; Brixner DI
Pharmacotherapy; 2006 Oct; 26(10):1438-45. PubMed ID: 16999654
[TBL] [Abstract][Full Text] [Related]
3. No difference in risk for thrombocytopenia during treatment of pulmonary embolism and deep venous thrombosis with either low-molecular-weight heparin or unfractionated heparin: a metaanalysis.
Morris TA; Castrejon S; Devendra G; Gamst AC
Chest; 2007 Oct; 132(4):1131-9. PubMed ID: 17646239
[TBL] [Abstract][Full Text] [Related]
4. How frequently is venous thromboembolism in heparin-treated patients associated with heparin-induced thrombocytopenia?
Levine RL; McCollum D; Hursting MJ
Chest; 2006 Sep; 130(3):681-7. PubMed ID: 16963663
[TBL] [Abstract][Full Text] [Related]
5. Heparin induced thrombocytopenia and thrombosis in a tertiary care hospital.
Ban-Hoefen M; Francis C
Thromb Res; 2009 Jun; 124(2):189-92. PubMed ID: 19195684
[TBL] [Abstract][Full Text] [Related]
6. Heparin-induced thrombocytopenia: natural history, diagnosis, and management.
Deitcher SR; Carman TL
Vasc Med; 2001; 6(2):113-9. PubMed ID: 11530963
[TBL] [Abstract][Full Text] [Related]
7. Heparin-induced thrombocytopenia (HIT): clinical and economic outcomes.
Baroletti S; Piovella C; Fanikos J; Labreche M; Lin J; Goldhaber SZ
Thromb Haemost; 2008 Dec; 100(6):1130-5. PubMed ID: 19132240
[TBL] [Abstract][Full Text] [Related]
8. [Heparin-induced thrombocytopenia: report of four cases in severely burned patients].
Bargues L; Foissaud V; Jault P; Samson T; Carsin H
Ann Fr Anesth Reanim; 2006; 25(11-12):1135-9. PubMed ID: 17034986
[TBL] [Abstract][Full Text] [Related]
9. Heparin induced thrombocytopenia.
Gupta S; Gupta MM
J Assoc Physicians India; 2008 Aug; 56():622-7. PubMed ID: 19051709
[TBL] [Abstract][Full Text] [Related]
10. Heparin-induced thrombocytopenia in intensive care patients.
Selleng K; Selleng S; Greinacher A
Semin Thromb Hemost; 2008 Jul; 34(5):425-38. PubMed ID: 18956282
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effectiveness and safety of low-molecular weight heparin versus unfractionated heparin anticoagulation after heart valve surgery.
Bucci C; Geerts WH; Sinclair A; Fremes SE
Am J Cardiol; 2011 Feb; 107(4):591-4. PubMed ID: 21184996
[TBL] [Abstract][Full Text] [Related]
12. Heparin-induced thrombocytopenia in patients with Philadelphia-negative myeloproliferative disorders and unusual splanchnic or cerebral vein thrombosis.
Randi ML; Tezza F; Scapin M; Duner E; Scarparo P; Scandellari R; Fabris F
Acta Haematol; 2010; 123(3):140-5. PubMed ID: 20134155
[TBL] [Abstract][Full Text] [Related]
13. Outcome of postoperative critically ill patients with heparin-induced thrombocytopenia: an observational retrospective case-control study.
Gettings EM; Brush KA; Van Cott EM; Hurford WE
Crit Care; 2006; 10(6):R161. PubMed ID: 17109753
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of infrastructure, equipment and training of 28 burn units/burn centers in Germany, Austria and Switzerland.
Vogt PM; Busche MN
Burns; 2011 Mar; 37(2):257-64. PubMed ID: 21087826
[TBL] [Abstract][Full Text] [Related]
15. Heparin-induced thrombocytopenia in neurologic patients treated with low-molecular-weight heparin.
Pohl C; Kredteck A; Bastians B; Hanfland P; Klockgether T; Harbrecht U
Neurology; 2005 Apr; 64(7):1285-7. PubMed ID: 15824368
[TBL] [Abstract][Full Text] [Related]
16. Heparin-induced thrombocytopenia.
Fabris F; Luzzatto G; Stefani PM; Girolami B; Cella G; Girolami A
Haematologica; 2000 Jan; 85(1):72-81. PubMed ID: 10629596
[TBL] [Abstract][Full Text] [Related]
17. Low-molecular-weight heparin in outpatient treatment of DVT.
Yeager BF; Matheny SC
Am Fam Physician; 1999 Feb; 59(4):945-52. PubMed ID: 10068716
[TBL] [Abstract][Full Text] [Related]
18. Heparin-induced thrombocytopenia: clinical manifestations and management strategies.
Menajovsky LB
Am J Med; 2005 Aug; 118 Suppl 8A():21S-30S. PubMed ID: 16125511
[TBL] [Abstract][Full Text] [Related]
19. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
[TBL] [Abstract][Full Text] [Related]
20. Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis.
Greinacher A; Warkentin TE
Expert Rev Hematol; 2008 Oct; 1(1):75-85. PubMed ID: 21083008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
